Literature DB >> 25022414

Management of rectal inflammatory myofibroblastic tumor recurrence.

Lan Sun, Lingli Tu, Xin Wang1, Hong Zhu, Jingzhi Mao, Hongyu Zhuo, Feng Xu.   

Abstract

Inflammatory myofibroblastic tumor (IMT) is an uncommon mesenchymal neoplasm of intermediate malignant potential. It may occur in various anatomic locations, but rarely in the rectum. This is a case discussion of a 36-year-old male patient with IMT of the rectum. After the patient underwent radical surgery, recurrence was seen after 18 months. Because the tumor was very close to the surrounding tissue, palliative tumor resection was performed followed by concurrent chemo-radiation and non-steroidal anti-inflammatory drugs (NSAID). After 2-year follow-up, the patient has no evidence of recurrence or metastasis. Surgical resection is very important for patient with rectal IMT, even in relapse cases. And adjuvant chemoradiotherapy and NSAID are in favor of the incompletely resected tumors as our case. But perhaps, the adjuvant treatments could be helpful after radical resection of rectal tumor.

Entities:  

Mesh:

Year:  2014        PMID: 25022414     DOI: 10.4103/0973-1482.136679

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  3 in total

Review 1.  Inflammatory myofibroblastic tumour of the colon: 2 case reports and a comprehensive review of the literature.

Authors:  Serkan Karaisli; Erdinc Kamer; Nese Ekinci; Fevzi Cengiz; Ahmet Er; Mustafa Peskersoy
Journal:  Int J Colorectal Dis       Date:  2020-02-25       Impact factor: 2.571

Review 2.  Rectal inflammatory myofibroblastic tumor: Case report and literature review.

Authors:  Hyung-Hoon Oh; Young-Eun Joo
Journal:  Medicine (Baltimore)       Date:  2021-08-20       Impact factor: 1.817

3.  Genetic Testing and Immunotherapy for Intracranial Inflammatory Myofibroblastic Tumor: A Case Report.

Authors:  Xiangji Meng; Lei Zhang; Qi Wang; Jimin Chen; Chunmei Zhang; Rongjie Tao; Yong Wang
Journal:  Onco Targets Ther       Date:  2022-04-01       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.